Truveta Launches Truveta Live Link

Why It Matters

Live Link transforms how therapeutic effectiveness and safety are measured, cutting research costs while delivering faster, compliant evidence for market access and regulatory decisions.

Key Takeaways

• Real-time EHR data linked with proprietary datasets.
• Enables prospective, longitudinal evidence generation.
• Reduces need for multiple vendors and costly trials.
• Supports audit‑ready, regulatory‑grade evidence for HEOR.
• Enhances therapy safety monitoring and market access.

Pulse Analysis

The surge in real‑world evidence (RWE) has reshaped pharmaceutical development, yet many organizations still rely on fragmented data sources and retrospective analyses. Traditional registries and clinical trials demand extensive time, budget, and coordination, often delaying critical insights into drug performance. By integrating daily refreshed electronic health records with external proprietary datasets, Truveta Live Link offers a unified view of patient journeys, from diagnoses to outcomes, enabling researchers to design forward‑looking studies without the latency inherent in legacy approaches.

Truveta Live Link distinguishes itself through a fully managed, compliant infrastructure that consolidates storage, de‑identification, and expert data curation under one roof. Leveraging HIPAA and HITRUST certifications, the platform ensures data security while simplifying governance, eliminating the need for multiple vendor contracts. Its multimodal data capture—including labs, imaging, clinical notes, and linked claims—produces audit‑ready evidence that meets regulatory standards, empowering health economics and outcomes research (HEOR), commercial, and market‑access teams to generate robust, actionable insights.

For the life‑science industry, the platform promises substantial cost savings and accelerated timelines. Prospective monitoring of therapy adoption, safety signals, and performance can occur daily, allowing companies to address evidence gaps earlier than competitors. This speed-to‑insight not only improves patient outcomes but also strengthens market positioning, as firms can substantiate value propositions with real‑time, regulatory‑grade data. As the demand for transparent, high‑quality RWE grows, solutions like Truveta Live Link are poised to become the new benchmark for evidence generation.